Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
2.Tiene citas relacionadas Cita con resumen
Law M, Wald N. Cholesterol, statins, and mortality. Lancet 2008;371:1161-2. [Ref.ID 82574]
3.
Wald N. Should folic acid fortification be mandatory?. BMJ 2007;334:1252. [Ref.ID 80355]
4.
Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005;330:1187-8. [Ref.ID 73867]
5.Tiene citas relacionadas
Wald N, Law M, Morris J, Rudnicka A4, Jordan R. "Polypill" to fight cardiovascular disease. Authors' reply. BMJ 2003;327:809-10. [Ref.ID 67735]
6.Tiene citas relacionadas Cita con resumen
Wald N, Law M. MRC/BHF Heart Protection Study. Lancet 2002;360:1781. [Ref.ID 64241]
7.Tiene citas relacionadas
Law M, Hackshaw A, Wald N. Screening mammography re-evaluated. Lancet 2000;355:749-50. [Ref.ID 49581]
8.Tiene citas relacionadas
Law M, Wald N. Authors' response. BMJ 1999;318:1479-80. [Ref.ID 45625]
9.Tiene citas relacionadas Cita con resumen
Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999;318:1471-80. [Ref.ID 45621]
10.
Wald N, Hackshaw A. Folic acid and prevention of neural-tube defects. Lancet 1997;350:665. [Ref.ID 35326]
11.
Wald N, Law M, Meade T, Miller G, Alberman E, Dickinson J. Use of personal medical records for research purposes. BMJ 1994;309:1422-4. [Ref.ID 23114]
12.
Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking?. BMJ 1994;308:21-6. [Ref.ID 20915]
13.
Wald N. Ethical issues in randomised preventions trials. BMJ 1993;306:563-5. [Ref.ID 18988]
14.
Jobst KA, Smith AD, Szatmari M, Molyneux A, Esiri ME, King E, Smith A, Jaskowski A, McDonald B, Wald N. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179-83. [Ref.ID 18339]
15.
Wald N. Suspended judgement. Does taking extra vitamins prevent spina bifida?. Control Clin Trial 1990;11:309-13. [Ref.ID 15782]
16. Cita con resumen
Forman D, Newell D G, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5. [Ref.ID 14906]
17. Cita con resumen
Wald N. Smoking and leukaemia. BMJ 1988;297:638. [Ref.ID 11829]
18.
Wald N, Doll R, Copeland G. Trends in tar, nicotine, and carbon monoxide yields of UK cigarettes manufactured since 1934. BMJ 1981;282:763-5. [Ref.ID 6170]
19.
Wald N, Idle M, Smith PG, Bailey A. Carboxyhaemoglobin levels in smokers of filter and plain cigarrettes. Lancet 1977;1:110-2. [Ref.ID 1772]
20. Cita con resumen
Wald N, Howard S, Smith PG, Kjeldsen K. Association between atherosclerotic diseases and carboxyhaemoglobin levels in tobacco smokers. BMJ 1973;1:761-5. [Ref.ID 1051]
Seleccionar todas
 
 1 a 20 de 20